Ixekizumab for Treating Moderate-to-Severe Plaque Psoriasis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Bram L.T. Ramaekers*, Robert F. Wolff, Xavier Pouwels, Marije Oosterhoff, Anoukh van Giessen, Gill Worthy, Caro Noake, Nigel Armstrong, Jos Kleijnen, Manuela A. Joore
*Corresponding author for this work
Research output: Contribution to journal › Article › Academic
Dive into the research topics of 'Ixekizumab for Treating Moderate-to-Severe Plaque Psoriasis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal'. Together they form a unique fingerprint.